Ribitol
|
Basic information |
| Metabolite name | Ribitol |
 | HMDB0000508 |
 |
C00474 |
 |
N/A |
| Synonyms | Ribitol; |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Ribitol |
| HMDB0000508 |
|
C00474 |
|
N/A |
| Synonyms | Ribitol; |
| No. of studies | 10 |
|
Relationship between Ribitol and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M042 | Type3 | fluoxetine group vs. control group | Cerebrospinal fluid | Rhesus monkey | Down |
| Study M097 | Type1 | depressed men group vs. control men group | Urine | Human | Down |
| Study M181 | Type3 | venlafaxine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Up |
| Study M536 | Type1 | naturally-occurring depression group vs. control group | Cerebrospinal fluid | Cynomolgus monkey | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M616 | Type1 | CUMS group vs. control group | Olfactory bulb | Sprague-Dawley rat | Down |
| Study M663 | Type3 | diterpene ginkgolides group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M980 | Type1 | CMS group vs. control group | Olfactory bulb | C57BL/6J mouse | Up |